Floatz logo

Therapeutic Asset Ratings

1,179 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ksq-001Ex
Cancer
M.D. Anderson Cancer CenterP1/2CC (40)
Navlimetostat
Non-Small Cell Lung Carcinoma
M.D. Anderson Cancer CenterP1/2CC (40)
ROCK2 INHIBITOR KD025
Plasma Cell Myeloma
M.D. Anderson Cancer CenterP1/2CC (40)
Tgfbr2 Ko Car27/Il-15 Nk Cells
Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1/2CC (40)
Trop2-Car-Nk
Ovarian Cancer
M.D. Anderson Cancer CenterP1/2CC (40)
Trop2-Car-Nk
Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1/2CC (40)
ACETIC
Cholangiocarcinoma
M.D. Anderson Cancer CenterP1C (39)
Adagrasib
Malignant Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1C (39)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Myelofibrosis
M.D. Anderson Cancer CenterP1C (39)
Axitinib
Metastatic Malignant Neoplasm
M.D. Anderson Cancer CenterP1C (39)
Capivasertib
Ovarian Cancer
M.D. Anderson Cancer CenterP1C (39)
Ceritinib
Metastatic Malignant Neoplasm
M.D. Anderson Cancer CenterP1C (39)
Elimusertib
Metastatic Malignant Neoplasm
M.D. Anderson Cancer CenterP1C (39)
FUROSEMIDE
Metastatic Melanoma
M.D. Anderson Cancer CenterP1C (39)
hc-7366
Kidney Cancer
M.D. Anderson Cancer CenterP1C (39)
im156
Malignant Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1C (39)
IPN 60090
Melanoma
M.D. Anderson Cancer CenterP1C (39)
Kite-753
B-Cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer CenterP1C (39)
Mesna
Metastatic Melanoma
M.D. Anderson Cancer CenterP1C (39)
Mrtx1719
Cancer
M.D. Anderson Cancer CenterP1C (39)
Rezatapopt
Myelodysplastic Syndrome
M.D. Anderson Cancer CenterP1C (39)
Valemetostat
Metastatic Malignant Neoplasm
M.D. Anderson Cancer CenterP1C (39)
Adavosertib
Peritoneal Carcinomatosis
M.D. Anderson Cancer CenterEarly P1C (39)
Adavosertib
Fallopian Tube Serous Adenocarcinoma
M.D. Anderson Cancer CenterEarly P1C (39)
Adavosertib
Ovarian Serous Adenocarcinoma
M.D. Anderson Cancer CenterEarly P1C (39)
Showing 1076 to 1100 of 1,179 assets
PreviousPage 44 of 48Next